Skip to content

Supply chain evaluation for foot orthotic provision in the NHS

Randomised controlled trial comparing the efficacy of foot orthoses produced by traditional and digital design processes, to reduce pressure and assess the impact on clinical practice

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN10978940
Enrollment
50
Registered
2015-11-04
Start date
2015-10-15
Completion date
Unknown
Last updated
2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Nutritional, Metabolic, Endocrine Diabetic Foot

Interventions

Participants are randomly allocated to one of two groups using computerised block randomisation. Group 1: Traditional Design and Manufacture Process: The geometry of t
varied hardness forefoot sections, cut outs, cut and fills and metatarsal bars material density used in additions will vary dependent on individual requirements. Top covers may be used where multiple

Sponsors

University of Salford
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged between 40 and 85 years 2. Have diabetes diagnosed by a medical practitioner 3. Have modular or bespoke (non standard) footwear provided by the orthotics department 4. Have all normal foot structures present 5. Be able to walk without a stick for 100 metres 6. Have sensory neuropathy as assessed by 10mg monofilament and vibratory perception at 3 of 10 sites on the foot and ankle 7. Have detectable pulse in foot and ankle (palpation or Doppler) 8. Must be capable of providing informed consent to participate

Exclusion criteria

Exclusion criteria: 1. Have had prior foot or ankle surgery 2. Have had prior major injuries to lower limb (e.g. fractures requiring internal fixation, skin grafts) 3. Have prior or active chronic foot or leg ulceration and without episode of ulceration within last 2 years. 4. Require heel pressure reduction intervention 5. Have had prescription foot orthoses via the orthotics department in the last 12 months 6. Co-morbidities (ischemia, renal, charcot arthorpathy)

Design outcomes

Primary

MeasureTime frame
Plantar pressure will be measured using an in shoe plantar pressure system which captures data concerning the distribution of weight across the bottom of the foot whilst wearing the orthotic insoles at baseline, 1, 2, 5 and 8 months.

Secondary

MeasureTime frame
1. Patient outcomes measured using validated questionnaires (EQ5D, ICECAP, FHSQ) at months 0, 1, 2, 5 and 8. 2. Compliance measured via telephone check-ups at months 3, 4, 5, 6, 7 and 8 3. Organisational outcomes measured using service data (number of appointments, number of foot wear and orthotic products supplied) at months 0 - 8 4. Service use data measured via a clinical service receipt inventory at months, 0 - 8

Countries

England, United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 22, 2026